'medically accepted tests'

In diabetes mellitus, polyneuropathy is an important complication and should be diagnosed as early as possible in order to prevent damage to the patient. Determination of warm, cold, and heat pain thresholds enables one to judge small nerve fibre sensitivity. Failure to perceive variances in temperature in the extremities is the most decisive early symptom of distal symmetric polyneuropathy, a typical ailment accompanying diabetes mellitus (Ziegler 1988). The Thermometry HCP may be used on patients with neurological diseases (especially peripheral neuropathy). The system is designed to measure and store patient responses to a series of thermal stimuli, but does not make any diagnosis. The test results should be used with the results of other medically accepted tests in order to assist the physician in making a final diagnosis. The product is highly accurate and truly calibrated to produce repeatable results. When the patients are properly explained and instructed before the testing, the results of the tests are highly sensitive, specific, and quantified. Features: • Full solid state Design PC enabled • Non invasive testing of pain thresholds • Range : 10 C to 500 C (Restricted for the purpose of safety) • Rate of change : 0.50 C per second for Hot/Cold • Helps to find Cool, Warm, Hot, and Cold Perception Thresholds • Data storage on Personal Computer. • Easy operation with hand remote • Helps detecting Diabetic Polyneuropathy at an early stage

Monofilaments MF10GM contain a small strand of filament attached to a visiting card-like handle. When placed upon the skin perpendicularly and applied an amount of pressure before the filament bends or buckles. The point at which the filament bends or buckles is rated in grams of force. 10gm Monofilament is widely accepted by the medical community and recommended by WHO and IDF for evaluating the loss of protective touch sense. The MF10GM Monofilament is intended to be used to determine whether a person with diabetes has the presence of an adequate level of protective sensation in their feet as indicated by having enough tactile sensitivity to perceive 10 grams of force against the skin of their feet. The monofilament is tested on multiple points on the foot of the person to be tested and they should feel the sense in the majority of the test points. If they don’t feel the sense in multiple spots, then it is indicated that they would have lost the protective touch sense. It should be used on adult Diabetic patients on a periodic basis to evaluate changes in sensory perception in the feet due to Diabetic peripheral sensory neuropathy. This device is not a complete replacement for routine sensory evaluation by a health care provider. They are available in a box of 25pcs and cost Rs. 650 inclusive of GST and Courier.

One of the frequent causes of non-traumatic lower-limb amputation is Diabetes and is usually preceded by foot ulcer and infection. The reason of this ulceration is commonly a loss of protective sensation due to peripheral neuropathy, for which there is no prevention strategy. Current research promotes early detection of neuropathy so that secondary prevention measures, such as intensive foot-care education and treatment, can be used for individuals. In an effort to standardize and simplify the detection of insensate foot, the 5.07/10-gm Monofilament is recommended by the International Diabetes Federation and the World Health Organization as a device that can be used by health professionals at every level of care. A standardised filament is pressed against part of the foot. When the filament bends, its tip is exerting a pressure of 10 grams (therefore this monofilament is often referred to as the 10 gram monofilament). If the patient cannot feel the monofilament at certain specified sites on the foot, he/she has lost enough sensation to be at risk of developing a neuropathic ulcer.